|
Volumn 23, Issue 2, 2008, Pages 1-3
|
Pharmacogenomics-based treatment of Helicobacter pylori infection.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ARTICLE;
ASIAN;
ETHNOLOGY;
GASTROINTESTINAL DISEASE;
GENETICS;
GENOTYPE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
PHARMACOGENETICS;
RANDOMIZED CONTROLLED TRIAL;
SAFETY;
TREATMENT OUTCOME;
UNITED STATES;
ANTI-BACTERIAL AGENTS;
ASIAN CONTINENTAL ANCESTRY GROUP;
DEVICE APPROVAL;
GASTROINTESTINAL DISEASES;
GENOTYPE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
PHARMACOGENETICS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 48249146145
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|